Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?

被引：17
|
作者：
Al-Khoury, S.
Afzali, B.
Shah, N.
Thomas, S.
Gusbeth-Tatomir, P.
Goldsmith, D.
Covic, A.
机构：
[1] C I Parhon Univ Hosp, Dialysis & Transplantat Ctr, Iasi 700503, Romania
[2] Guys Hosp, Dept Endocrinol & Diabet, London, England
[3] Guys Hosp, Dept Nephrol & Transplantat, London, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2007年 / 61卷 / 02期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1111/j.1742-1241.2006.01259.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Both chronic kidney disease (CKD) and type II diabetes mellitus (DM) are increasing in frequency among Western populations and both are potent risk factors for the development of anaemia. The presence of CKD and diabetes together represent the most important aetiopathogenic combination for the development of anaemia. New evidence has highlighted some of the underlying mechanisms which make diabetic patients more susceptible to dyserythropoiesis, particularly once they have developed concomitant CKD. In addition, recent publications from large-scale epidemiological studies have highlighted the impact of anaemia on diabetic patients. The purpose of this review was to focus on the pathophysiology and impact of anaemia in DM.
引用
收藏
页码：281 / 289
页数：9
相关论文
共 50 条
  • [41] New Strategies for Anaemia Management in Chronic Kidney Disease
    Locatelli, Francesco
    Del Vecchio, Lucia
    [J]. SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 2017, 189 : 184 - 188
  • [42] The importance of early treatment of the anaemia of chronic kidney disease
    Eknoyan, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 45 - 49
  • [43] Association of renal function with anaemia in diabetic kidney disease
    Martynov, S. A.
    Shestakova, M. V.
    Suntsov, Y. I.
    Maslova, O. V.
    Dedov, I. I.
    [J]. DIABETOLOGIA, 2010, 53
  • [44] The "adult inactivity triad" in patients with chronic kidney disease: A review
    Zhang, Fan
    Yin, Xiaojing
    Huang, Liuyan
    Zhang, Huachun
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [45] Cytokines, Atherogenesis, and Hypercatabolism in Chronic Kidney Disease: A Dreadful Triad
    Carrero, Juan Jesus
    Park, Sun-Hee
    Axelsson, Jonas
    Lindholm, Bengt
    Stenvinkel, Peter
    [J]. SEMINARS IN DIALYSIS, 2009, 22 (04) : 381 - 386
  • [46] Cardiac impact of anemia correction with epoetin beta in patients with diabetes and chronic kidney disease: results of the anaemia correction in diabetes (ACORD) study
    Ritz, E.
    Bilous, R. W.
    De Alvaro, F.
    Laville, M.
    O'donoghue, D. J.
    Scherhag, A.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 521 - 521
  • [47] Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002
    Stevens, LA
    Levin, A
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (02): : 133 - 138
  • [48] Effect of finerenone in patients with chronic kidney disease and type 2 diabetes by baseline anaemia status: a FIDELITY analysis
    Singh, A.
    Anker, S. D.
    Filippatos, G.
    Pitt, B.
    Rossing, P.
    Ruilope, L. M.
    Farjat, A. E.
    James, G.
    Farag, Y. M. K.
    Roberts, L.
    Bakris, G.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [49] Intravenous iron use in anaemia associated with chronic kidney disease: do patients with and without diabetes respond similarly?
    Mostafa, S. A.
    Burdenw, A. C.
    Tagboto, S.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [50] PLAGUE IN INDIA - TIME TO FORGET THE SYMPTOMS AND TACKLE THE DISEASE
    不详
    [J]. LANCET, 1994, 344 (8929): : 1033 - 1035
12345